The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prebiotics and resistance to gastrointestinal infections
Open accessAbstract
Acute gut disorder is a cause for significant medicinal and economic concern. Certain individual pathogens of the gut, often transmitted in food or water, have the ability to cause severe discomfort. There is a need to manage such conditions more effectively. The route of reducing the risk of intestinal infections through diet remains largely unexplored. Antibiotics are effective at inhibiting pathogens; however, these should not be prescribed in the absence of disease and therefore cannot be used prophylactically. Moreover, their indiscriminate use has reduced effectiveness. Evidence has accumulated to suggestthat some of the health-promoting bacteria in the gut (probiotics) can elicit a multiplicity of inhibitory effects against pathogens. Hence, an increase in their numbers should prove effective at repressing pathogen colonisation if/when infectious agents enter the gut. As such, fortification of indigenous bifidobacteria/lactobacilli by using prebiotics should improve protection. There are a number of potential mechanisms for lactic acid bacteria to reduce intestinal infections. Firstly, metabolic endproducts such as acids excreted by these micro-organisms may lower the gut pH to levels below those at which pathogens are able to effectively compete. Also, many lactobacilli and bifidobacteria species are able to excrete natural antibiotics, which can have a broad spectrum of activity. Other mechanisms include an improved immune stimulation, competition for nutrients and blocking of pathogen adhesion sites in the gut. Many intestinal pathogens like type 1 fimbriated Escherichia coli, salmonellae and campylobacters utilise oligosaccharide receptor sites in the gut. Once established, they can then cause gastroenteritis through invasive and/or toxin forming properties. One extrapolation of the prebiotic concept is to simulate such receptor sites in the gut lumen. Hence, the pathogen is ‘decoyed’ into not binding at the host mucosal interface. The combined effects of prebiotics upon the lactic acid flora and anti-adhesive strategies may lead towards new dietary interventions against food safety agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,528
Self-citationCommon themes in microbial pathogenicity
Finlay, B. B., & Falkow, S. (1989) · Microbiological Reviews · doi:10.1128/mmbr.53.2.210-230.1989 · Cited by 768
Production, properties and applications of food-grade oligosaccharides
Crittenden, R. G., & Playne, M. J. (1996) · Trends in Food Science & Technology · doi:10.1016/s0924-2244(96)10038-8 · Cited by 687
ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIA
Karlsson, K.-A. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001521 · Cited by 683
Regulatory effects of bifidobacteria on the growth of other colonic bacteria
Gibson, G. R., & Wang, X. (1994) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1994.tb03443.x · Cited by 682
Self-citationWang, X., & Gibson, G. R. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02790.x · Cited by 663
Self-citationEffects of Fructooligosaccharides on Intestinal Flora and Human Health
HIDAKA, H., EIDA, T., TAKIZAWA, T., TOKUNAGA, T., & TASHIRO, Y. (1986) · Bifidobacteria and Microflora · doi:10.12938/bifidus1982.5.1_37 · Cited by 598
Kleessen, B., Sykura, B., Zunft, H., & Blaut, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1397 · Cited by 585
Bifidobacteria and their role in human health
Mitsuoka, T. (1990) · Journal of Industrial Microbiology · doi:10.1007/bf01575871 · Cited by 385
Buddington, R., Williams, C., Chen, S., & Witherly, S. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.709 · Cited by 291
Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture
Gibson, G. (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90606-8 · Cited by 219
Self-citationDietary Oligofructose and Inulin Protect Mice from Enteric and Systemic Pathogens and Tumor Inducers
Buddington, K. K., Donahoo, J. B., & Buddington, R. K. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.3.472 · Cited by 210
Bifidogenic properties of different types of fructo-oligosaccharides
Gibson, G. R., & Wang, X. (1994) · Food Microbiology · doi:10.1006/fmic.1994.1055 · Cited by 177
Self-citationA study of fructo oligosaccharides in the prevention of travellers’ diarrhoea
Cummings, J. H., Christie, S., & Cole, T. J. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01043.x · Cited by 163
Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M., & Tanaka, R. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01461.x · Cited by 147
Sghir, A., Chow, J., & Mackie, R. I. (1998) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.1998.00590.x · Cited by 135
Park, S. F., & Kroll, R. G. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01609.x · Cited by 129
Tuohy, K. M., Finlay, R. K., Wynne, A. G., & Gibson, G. R. (2001) · Anaerobe · doi:10.1006/anae.2001.0368 · Cited by 121
Self-citationProbiotics 2 : applications and practical aspects
Fuller, R. (1997) · Chapman & Hall, Ltd. eBooks · Cited by 120
Influence of Dietary Neosugar on Selected Bacterial Groups of the Human Faecal Microbiota
Williams, C. H., Witherly, S. A., & Buddington, R. K. (1994) · Microbial Ecology in Health and Disease · doi:10.3109/08910609409141577 · Cited by 101
Oli, M. W., Petschow, B. W., & Buddington, R. K. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018892524790 · Cited by 96
Probiotics and Intestinal Infections
Gibson, G. R., Saavedra, J. M., Macfarlane, S., & Macfarlane, G. T. (1997) · Springer eBooks · doi:10.1007/978-94-011-5860-2_2 · Cited by 93
Self-citationMcBain, A. J., & Macfarlane, G. T. (1997) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1997.11720715 · Cited by 80
Brück, W. M., Kelleher, S. L., Gibson, G. R., Nielsen, K. E., Chatterton, D. E. W., & Lönnerdal, B. L. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200309000-00014 · Cited by 79
Self-citationNon-digestible oligosaccharides and bifidobacteria - implications for health
Gibson, G. R., Willis, C. L., & Loo, J. V. (1994) · International sugar journal · Cited by 62
Self-citationHeerze, L. D., Kelm, M. A. L. T. E., Talbot, J., & Armstrong, G. D. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1291 · Cited by 57
Functional and nutritional foods containing bifidogenic factors
Mizota, T. (1996) · Bulletin. International Dairy Federation · Cited by 28
Gastrointestinal microbial disease
Gibson, G. R., Saavedra, J. M., Macfarlane, S., & Macfarlane, G. T. (1997) · Cited by 11
Self-citation
Cited by
Interactions of gut microbiota with functional food components and nutraceuticals
Laparra, J. M., & Sanz, Y. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.001 · Cited by 684
Review article: prebiotics in the gastrointestinal tract
MACFARLANE, S., MACFARLANE, G. T., & CUMMINGS, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03042.x · Cited by 621
Short-chain fatty acids: ready for prime time?
Roy, C. C., Kien, C. L., Bouthillier, L., & Levy, E. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021004351 · Cited by 443
Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., Rizzello, F., Campieri, M., & Brigidi, P. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.04.012 · Cited by 398
Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions
Gourbeyre, P., Denery, S., & Bodinier, M. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109753 · Cited by 394
Metadata
- Authors
- Gibson, G. R., McCartney, A. L., & Rastall, R. A.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-04
- Volume
- 93
- Issue
- S1
- Pages
- S31-S34
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W1986499171
- Cited by
- 275
- References
- 28
- FWCI
- 21.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.